⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors
globenewswire.com
ONCY
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
globenewswire.com
GTBP
VIR
ONCY
SNSE
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
globenewswire.com
ONCY